Annual report [Section 13 and 15(d), not S-K Item 405]

Statements of Cash Flows

v3.26.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (7,558,557) $ (12,287,461)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 143,732 657,649
Increase (decrease) in cash resulting from changes in:    
Prepaid expenses and other current assets 30,470 168,181
Accounts payable (388,056) (108,512)
Accrued and other current liabilities 14,852 407,195
Net cash used in operating activities (7,757,559) (11,162,948)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs 12,167,852 6,886,102
Payment of prior period issuance costs (50,495)
Proceeds from exercise of pre-funded warrants 977 1,109
Payment for fractional shares in reverse stock split (367) (828)
Net cash provided by financing activities 12,117,967 6,886,383
Net increase (decrease) in cash and cash equivalents 4,360,408 (4,276,565)
Cash and cash equivalents at beginning of period 3,161,570 7,438,135
Cash and cash equivalents at end of period 7,521,978 3,161,570
Supplemental disclosure:    
Cash paid for taxes 950 950
Non-cash financing activities:    
Issuance of abeyance shares (18)
Issuance costs in accounts payable or accrued expenses $ 91,352 $ 50,495